Aquestive Therapeutics Reports First Quarter 2019 Financial Results and Recent Business Highlights

Go back to Aquestive Therapeutics Reports First Quarter 2019 Financial Results and Recent Business Highlights

Aquestive Therapeutics Inc. (AQST) Misses Q1 EPS by 9c

May 8, 2019 7:16 AM EDT

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q1 EPS of ($0.59), $0.09 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $11.59 million.

GUIDANCE:

Aquestive Therapeutics Inc. sees FY2019 revenue of $33-45 million,... More